FDA approves Allergan’s dermal filler: 4 things to know

The Food and Drug Administration on Monday approved Allergan’s dermal filler for the correction of moderate to severe facial wrinkles and folds.

Advertisement
By: Mackenzie Bean

Here are four things to know.

1. Juvederm Vollure XC is approved for patients 21 years and older.

2. The dermal filler is a gel product made from several types of hyaluronic acid.

2. The treatment lasts for up to 18 months.

3. Alelrgan said Juvederm Vollure XC will be available to physicians this April.

More articles on supply chain:

Study: Amgen cholesterol drug lowers risk of heart disease, stroke by 20%
Novo Nordisk CEO: ‘Patients shouldn’t pay list price for our drugs’
CVS Health launches prescription savings program with Novo Nordisk

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott launches residual cancer test

    Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

    By: Elizabeth Gregerson

  • Supply chain leaders' $1M wish lists

    Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

    By: Ella Jeffries

  • 10 systems seeking supply chain leaders

    As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

    By: Ella Jeffries
Advertisement

Comments are closed.